bioAffinity Technologies, Inc. (BIAFW)
Detects early-stage lung cancer from sputum samples using flow cytometry analysis.
$0.09+0.00%
StockGlow Score
Neutral
BearishBullish
The outlook
bioAffinity Technologies (BIAFW) trades at $0.0875 with no material movement today. Analyst coverage and trend data are unavailable, making it difficult to assess where the stock sits relative to recent ranges or consensus targets. The neutral score reflects limited public information.
What’s behind the score
Analyst and trend data are thin for this ticker right now.
Market cap
—
52-wk high
$0.09
52-wk low
$0.09
50-day avg
—
200-day avg
—
Trailing P/E
—